In contrast, other studies have found that anti-VEGF-A treatment has no effect on early renal pathology [25], and that podocyte-specific deletion of Vegfa in diabetic mice causes increased proteinuria and kidney damage [21]. The gene discussed is VEGFA; the disease is Nephropathy.